MetLife Inc., US59156R1086

Jefferies keeps Buy rating for MetLife stock at USD 115.00 target

Published on 10/02/2026 at 15:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife sees at least USD 600 million pre-tax in the third quarter. MetLife stock costs EUR 84.16 on October 2, 2026 versus EUR 83.92, plus 0.29 percent.

Isometrische Illustration einer Prozesskette mit Familie, Haus, Auto und Schutzschild
Isometrische 3D-Grafik zeigt die Versicherungs-Wertschöpfungskette, illustrativ und thematisch passend zu MetLife Inc., ISIN US59156R1086, Illustration mit AI erstellt.

MetLife (ISIN US59156R1086) was trading at EUR 84.16 at Lang & Schwarz on October 2, 2026 at 3:37 p.m. CEST, up 0.29 percent versus the prior close of EUR 83.92. On October 1, 2026, Jefferies analyst Suneet Kamath maintained a Buy rating and a USD 115.00 price target, as Markets Insider reported.

Jefferies keeps target at USD 115.00

The analyst action gives the stock a fresh valuation reference while leaving the recommendation unchanged. The USD 115.00 target stands USD 20.33 above the Lang & Schwarz price, but the currencies differ, so the target is not converted into a euro percentage.

The report also cited MetLife's second-quarter results for the period ended June 30, 2026. Revenue was USD 18.88 billion and net profit was USD 736 million, compared with USD 17.18 billion and USD 729 million a year earlier, according to Markets Insider.

Variable income sets the next test

MetLife estimated at least USD 600 million of pre-tax variable investment income for the quarter ended September 30, 2026. The estimate is preliminary and unaudited, and actual results could differ materially because the quarter-end closing process was still incomplete, according to StockTitan.

The comparison point is MetLife's full-year 2026 variable investment income guidance of USD 1.6 billion, while the company scheduled its third-quarter earnings release and financial supplement for November 4, 2026, the filing summary said. That date gives investors a defined checkpoint for testing the preliminary estimate against reported results.

In the second quarter of 2026, adjusted earnings rose 15 percent to USD 1.6 billion and adjusted earnings per share increased 20 percent to USD 2.43. Premiums, fees and other revenues grew 7 percent to USD 13.7 billion, while adjusted return on equity reached 17.0 percent, according to StockTitan.

MetLife stock remains below its yearly high

On the NYSE, MetLife was last quoted at USD 94.67 on October 2, 2026 at 9:49 a.m. EDT. The finance data showed a 52-week range of USD 67.33 to USD 100.93 and a market capitalization of USD 60.9 billion on the same date, placing the primary-exchange quote below the yearly high.

The euro quote carries a separate German-market reference. MetLife was trading at EUR 84.16 at Lang & Schwarz on October 2, 2026 at 3:37 p.m. CEST, plus 0.29 percent versus the EUR 83.92 prior close at Lang & Schwarz. The further course of trading is shown by the continuously updated real-time quote of MetLife stock.

MetLife stock at a glance

  • Company: MetLife, Inc.
  • ISIN: US59156R1086
  • Ticker: MET
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 2, 2026, 3:37 p.m. CEST: EUR 84.16
  • Change versus prior close: plus 0.29 percent
  • Prior close Lang & Schwarz October 1, 2026: EUR 83.92
  • Market capitalization: USD 60.9 billion as of October 2, 2026
  • 52-week range: USD 67.33-100.93 as of October 2, 2026
  • Sector / Industry: Financial Services / Insurance - Life
  • Next earnings date: November 4, 2026

More news and analyses on MetLife stock

Disclaimer...

en | US59156R1086 | METLIFE INC. | boerse | 70216008 | bgmi